Paul H. Gale

1.5k total citations
32 papers, 1.1k citations indexed

About

Paul H. Gale is a scholar working on Molecular Biology, Biochemistry and Pharmacology. According to data from OpenAlex, Paul H. Gale has authored 32 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 14 papers in Biochemistry and 12 papers in Pharmacology. Recurrent topics in Paul H. Gale's work include Coenzyme Q10 studies and effects (12 papers), Inflammatory mediators and NSAID effects (9 papers) and Eicosanoids and Hypertension Pharmacology (7 papers). Paul H. Gale is often cited by papers focused on Coenzyme Q10 studies and effects (12 papers), Inflammatory mediators and NSAID effects (9 papers) and Eicosanoids and Hypertension Pharmacology (7 papers). Paul H. Gale collaborates with scholars based in United States, United Kingdom and Germany. Paul H. Gale's co-authors include Robert W. Egan, F. A. Kuehl, Karl Folkers, A. C. Page, Edward A. Ham, D.D. Soderman, W.J.A. Vandenheuvel, Frank R. Koniuszy, Nelson R. Trenner and Byron H. Arison and has published in prestigious journals such as Nature, Journal of the American Chemical Society and Journal of Biological Chemistry.

In The Last Decade

Paul H. Gale

32 papers receiving 971 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Paul H. Gale United States 18 530 355 241 178 172 32 1.1k
D. Hegner Germany 25 909 1.7× 124 0.3× 121 0.5× 406 2.3× 104 0.6× 80 2.0k
Chozo Mitoma United States 20 438 0.8× 171 0.5× 142 0.6× 145 0.8× 90 0.5× 39 1.2k
Shinji Terao Japan 21 461 0.9× 146 0.4× 328 1.4× 342 1.9× 324 1.9× 45 1.5k
J.H. Fellman United States 21 358 0.7× 170 0.5× 93 0.4× 152 0.9× 138 0.8× 58 1.1k
Rita A. Halpin United States 20 695 1.3× 141 0.4× 249 1.0× 161 0.9× 70 0.4× 23 1.4k
Arthur W. Bull United States 20 637 1.2× 327 0.9× 185 0.8× 162 0.9× 96 0.6× 38 1.3k
Ann F. Welton United States 25 885 1.7× 133 0.4× 180 0.7× 451 2.5× 169 1.0× 64 1.9k
Alvah H. Phillips United States 11 899 1.7× 313 0.9× 100 0.4× 174 1.0× 99 0.6× 16 1.9k
Vincent G. Zannoni United States 25 709 1.3× 308 0.9× 86 0.4× 317 1.8× 80 0.5× 58 2.0k
Joseph Jarabak United States 23 584 1.1× 166 0.5× 297 1.2× 140 0.8× 111 0.6× 46 1.4k

Countries citing papers authored by Paul H. Gale

Since Specialization
Citations

This map shows the geographic impact of Paul H. Gale's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul H. Gale with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul H. Gale more than expected).

Fields of papers citing papers by Paul H. Gale

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul H. Gale. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul H. Gale. The network helps show where Paul H. Gale may publish in the future.

Co-authorship network of co-authors of Paul H. Gale

This figure shows the co-authorship network connecting the top 25 collaborators of Paul H. Gale. A scholar is included among the top collaborators of Paul H. Gale based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul H. Gale. Paul H. Gale is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hardy, Seth M., et al.. (2011). Prevalence of Fusobacterium necrophorum in persistent sore throat samples. British Journal of Biomedical Science. 68(4). 209–210. 7 indexed citations
2.
Egan, Robert W., et al.. (1990). Naphthalenes as inhibitors of myeloperoxidase: Direct and indirect mechanisms of inhibition. Inflammation Research. 29(3-4). 266–276. 6 indexed citations
3.
Harvison, Peter J., et al.. (1988). Acetaminophen and analogs as cosubstrates and inhibitors of prostaglandin H synthase. Chemico-Biological Interactions. 64(3). 251–266. 43 indexed citations
4.
Bonney, Robert J., P. M. Davies, Harry W. Dougherty, et al.. (1987). Biochemical and biological activities of 2,3-dihydro-6-[3-(2-hydroxymethyl)phenyl-2-propenyl]-5-benzofuranol (L-651,896), a novel topical anti-inflammatory agent. Biochemical Pharmacology. 36(22). 3885–3891. 9 indexed citations
5.
Harvison, Peter J., Robert W. Egan, Paul H. Gale, & Sidney D. Nelson. (1986). Acetaminophen as a Cosubstrate and Inhibitor of Prostaglandin H Synthase. Advances in experimental medicine and biology. 197. 739–747. 14 indexed citations
6.
Egan, Robert W. & Paul H. Gale. (1985). Inhibition of mammalian 5-lipoxygenase by aromatic disulfides.. Journal of Biological Chemistry. 260(21). 11554–11559. 33 indexed citations
7.
Egan, Robert W., Paul H. Gale, W.J.A. Vandenheuvel, et al.. (1981). Oxidation reactions by prostaglandin cyclooxygenase-hydroperoxidase.. Journal of Biological Chemistry. 256(14). 7352–7361. 92 indexed citations
8.
Gale, Paul H. & Robert W. Egan. (1980). Polarographic assay for phospholipase A2. Analytical Biochemistry. 104(2). 489–493. 6 indexed citations
9.
Egan, Robert W., Paul H. Gale, W.J.A. Vandenheuvel, & Frederick A. Kuehl. (1979). Peroxidase Reactions during Prostaglandin Biosynthesis and their Relationship to Inflammation. Birkhäuser Basel eBooks. 39–49. 2 indexed citations
10.
Egan, Robert W., Paul H. Gale, & F. A. Kuehl. (1979). Reduction of hydroperoxides in the prostaglandin biosynthetic pathway by a microsomal peroxidase.. Journal of Biological Chemistry. 254(9). 3295–3302. 129 indexed citations
12.
Gale, Paul H., Byron H. Arison, Nelson R. Trenner, et al.. (1963). Characterization of Vitamin K9(H) from Mycobacterium phlei. Biochemistry. 2(1). 200–203. 47 indexed citations
13.
Page, A. C., Malcolm Smith, Paul H. Gale, D. Polin, & Karl Folkers. (1963). Coenzyme Q. XXXII. Coenzyme Q and the maintenance of sperm cells in Vitro. Archives of Biochemistry and Biophysics. 101(2). 204–208. 2 indexed citations
14.
Gale, Paul H., Byron H. Arison, Nelson R. Trenner, A. C. Page, & Karl Folkers. (1963). Coenzyme Q. XXXVI. Isolation and Characterization of Coenzyme Q10 (H-10). Biochemistry. 2(1). 196–200. 31 indexed citations
15.
Gale, Paul H., A. C. Page, T.H. Stoudt, & Karl Folkers. (1962). Identification of Vitamin K2(35), an Apparent Cofactor of a Steroidal 1-Dehydrogenase of Bacillus sphaericus*. Biochemistry. 1(5). 788–792. 17 indexed citations
16.
Krisch, K, et al.. (1962). On the presence and significance of coenzyme Q in microsomes. Archives of Biochemistry and Biophysics. 96(3). 580–582. 30 indexed citations
17.
Page, A. C., Malcolm Smith, Paul H. Gale, D. Polin, & Karl Folkers. (1961). Coenzyme Q. XXVIII. Activity of the coenzyme Q group in sperm motility. Biochemical and Biophysical Research Communications. 6(2). 141–145. 3 indexed citations
18.
Gale, Paul H., Frank R. Koniuszy, A. C. Page, Karl Folkers, & Henry Siegel. (1961). Coenzyme Q. XXIV. On the significance of coenzyme Q 10 in human tissues. Archives of Biochemistry and Biophysics. 93(2). 211–213. 22 indexed citations
19.
Koniuszy, Frank R., Paul H. Gale, A. C. Page, & Karl Folkers. (1960). Coenzyme Q. XIII. Isolation, assay and human urinary levels of coenzyme Q10. Archives of Biochemistry and Biophysics. 87(2). 298–305. 22 indexed citations
20.
Linn, Bruce O., et al.. (1959). Coenzyme Q. VII. Isolation and Distribution of Coenzyme Q10 in Animal Tissues. Journal of the American Chemical Society. 81(15). 4007–4010. 86 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026